SVB Wealth’s 9 Meters Biopharma NMTR Stock Holding History

SVB Wealth’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,300	Closed	-$34K	–	975
2021 Q3	$34K	Buy	+1,300	New	+$30.6K	﹤0.01%	966

Other funds holding NMTR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SVB Wealth's NMTR Position: Q4 2021 in Review

SVB Wealth sold out of 9 Meters Biopharma (NMTR) in Q4 2021, closing a stake of 1,300 shares — an estimated $34K sold.

SVB Wealth first reported a position in NMTR in Q3 2021 and held it in 1 quarter. The position peaked at $34K in Q3 2021. 104 funds tracked by Wall St. Rank hold NMTR as of Q4 2021.

SVB Wealth reported no remaining 9 Meters Biopharma position as of Q4 2021 after selling out during the quarter.
SVB Wealth sold 1,300 9 Meters Biopharma shares in Q4 2021, an estimated $34K.
SVB Wealth first reported a position in 9 Meters Biopharma in Q3 2021 and held it in 1 quarter.
SVB Wealth's 9 Meters Biopharma position peaked at $34K in Q3 2021.
104 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2021.

Based on SVB Wealth's 13F filing for Q4 2021, filed 15 Feb 2022.